MedPath

Evaluation of an eHealth type 2 diabetes risk reduction program for weight loss in women with a history of gestational diabetes

Conditions
Gestational diabetes
Obesity
Type 2 diabetes
Diet and Nutrition - Obesity
Metabolic and Endocrine - Diabetes
Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy
Registration Number
ACTRN12619000162112
Lead Sponsor
Professor Clare Collins
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
120
Inclusion Criteria

had a gestational diabetes diagnosis in the last two years
- are at least 3 months post-partum
- have a Body Mass Index between 25 and 50 kg/m2

Exclusion Criteria

- Are currently pregnant or trying to fall pregnant
- Have an orthopaedic and/or medical condition that may impact on your ability to safely participate in exercise or you have been diagnosed with diabetes (Type 1 or 2).
-Do not pass the pre-exercise screening tool (or you cannot obtain a Dr’s clearance if do you not pass the screener) for safety to engage in physical activity.
- have a smartphone, desktop computer, laptop or tablet computer and access to a broadband Internet connection suitable for conducting video calls (e.g. Skype).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Weight (kg); participant reported[baseline and 12 weeks (primary timepoint)]
Secondary Outcome Measures
NameTimeMethod
Dietary intake measured using the Australian Eating Survey (FFQ) [baseline and 12 weeks ];Physical activity measured by Godin Leisure-time Exercise Questionnaire[baseline and 12 weeks ];Quality of Life measured using the AQoL-6D[baseline and 12 weeks ];Eating behaviours measured using the Three Factor Eating Questionnaire[baseline and 12 weeks];Eating self-efficacy measured using the Weight Efficacy Lifestyle Questionnaire-Short Form[baseline and 12 weeks];Self-efficacy in relation to physical activity measured using the Self-efficacy for Exercise Scale[baseline and 12 weeks];Habit formation using the Self-report Habit Index[baseline and 12 weeks];Program process evaluation questionnaire completed by participants designed specifically for this study.[12 weeks ];Addictive eating behaviours measured using the Modified Yale Food Addition Scale[baseline and 12 weeks]
© Copyright 2025. All Rights Reserved by MedPath